In May, Texans’ access to abortion drug mifepristone was thrown into disarray after a federal appeals court ruled that people across the country must obtain the drug in person, and then, three days later, the Supreme Court temporarily blocked that ruling.
The 5th U.S. Circuit Court of Appeals’ ruling, stemming from a Louisiana lawsuit, would block a 2023 Food and Drug Administration rule allowing mifepristone to be delivered by mail — a provision commonly used to get around Texas’ abortion ban.
